AL
TVTX icon

Airain Ltd’s Travere Therapeutics TVTX Stock Holding History

Airain Ltd’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$422K Buy
+21,753
New +$395K 0.02% 577
2016
Q4 		– Sell
-50,606
Closed -$1.13M – 853
2016
Q3 		$1.13M Buy
+50,606
New +$963K 0.07% 312
2016
Q1 		– Sell
-44,456
Closed -$858K – 1070
2015
Q4 		$858K Buy
44,456
+34,326
+339% +$686K 0.06% 339
2015
Q3 		$205K Buy
+10,130
New +$300K 0.01% 703

Other funds holding TVTX

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Airain Ltd's TVTX Position: Q2 2017 in Review

Airain Ltd opened a new position in Travere Therapeutics (TVTX) in Q2 2017: 21,753 shares worth $422K. The stake represents 0.02% of the portfolio and ranks #577 among its holdings. This is a return to the name: Airain Ltd previously reported a position in TVTX as recently as Q3 2016.

Airain Ltd first reported a position in TVTX in Q3 2015 and has held it in 4 quarters since. The position peaked at $1.13M in Q3 2016. 108 funds tracked by Wall St. Rank hold TVTX as of Q2 2017.

  • Airain Ltd held 21,753 shares of Travere Therapeutics worth $422K as of Q2 2017.
  • Travere Therapeutics was a new Airain Ltd position in Q2 2017.
  • Travere Therapeutics made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #577 holding.
  • Airain Ltd first reported a position in Travere Therapeutics in Q3 2015 and has held it in 4 quarters since.
  • Airain Ltd's Travere Therapeutics position peaked at $1.13M in Q3 2016.
  • 108 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.